For Budget 2025, Arthritis Foundation Malaysia & Psoriasis Association of Malaysia want a special RM20 million programme for the treatment of autoimmune diseases, biosimilars included in the national formulary, and a government-industry-patient mechanism.
Common steroid treatments for the autoimmune disease lupus can cause as many problems as they solve, but researchers are close to finding a viable alternative.
As we learn more about the links between our gut microbiomes and autoimmune disease, it's hoped new insights will also offer new ways to treat these disorders.
Arthritis Foundation Malaysia and Psoriasis Association of Malaysia back MOH's proposal for a national health insurance scheme, saying this will boost access to expensive biologics that cost RM20,000-RM50,000 annually. Targeted therapies are an investment.